The addition of transdermal delivery of neostigmine and glycopyrrolate by iontophoresis to thrice weekly bowel care in persons with spinal cord injury: A pilot study

William A. Bauman, Anton Sabiev, Shahzad Shallwani, Ann M. Spungen, Christopher M. Cirnigliaro, Mark A. Korsten

Research output: Contribution to journalArticlepeer-review

Abstract

Persons with spinal cord injury (SCI) have neurogenic bowel disorders characterized by difficulty with evacuation (DWE), fecal incontinence, and discoordination of defecation. Six medically stable in‐patients with SCI with a mean age of 57 ± 10 years (range: 39–66 years) and time since injury of 18 ± 17 years (range: 3–47 years) were investigated. Standard of care (SOC) for bowel care was followed by two weeks of SOC plus neostigmine (0.07 mg/kg) and glycopyrrolate (0.014 mg/kg) administered transcutaneously by iontophoresis thrice weekly for two weeks while patients continued to receive SOC. The primary endpoint was time to bowel evacuation. Body weights and abdominal radiographs were obtained. Ten questions related to bowel function and the Treatment Satisfaction Questionnaire for Medication were acquired after each arm. Bowel evacuation time decreased after the dual drug intervention arm (106.9 ± 68.4 vs. 40.8 ± 19.6 min; p < 0.0001). Body weight decreased (2.78 ± 0.98 kg; p < 0.0001), a finding confirmed on abdominal radiograph. Both questionnaires demonstrated improvement after the dual drug intervention arm. No major adverse events occurred. The addition of neostigmine and glycopyrrolate by transcutaneous administration to SOC for bowel care in persons with SCI and DWE resulted in the safe, effective, and predictable bowel evacuation with subjective improvement in bowel care.

Original languageEnglish
Article number1135
Pages (from-to)1-11
Number of pages11
JournalJournal of Clinical Medicine
Volume10
Issue number5
DOIs
StatePublished - 1 Mar 2021

Keywords

  • Difficulty with evacuation
  • Glycopyrrolate
  • Iontophoresis
  • Neostigmine
  • Neurogenic bowel
  • Spinal cord injury

Fingerprint

Dive into the research topics of 'The addition of transdermal delivery of neostigmine and glycopyrrolate by iontophoresis to thrice weekly bowel care in persons with spinal cord injury: A pilot study'. Together they form a unique fingerprint.

Cite this